Commentary: decoding the neurochemical basis of resistance to stress.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 22291403)

Published in J Psychopharmacol on January 01, 1992

Authors

R Yehuda1, E L Giller

Author Affiliations

1: UConn Medical Center, Psychiatry, Farmington, CT 06030-2103, USA.

Articles by these authors

Low urinary cortisol excretion in Holocaust survivors with posttraumatic stress disorder. Am J Psychiatry (1995) 2.39

Relationship between posttraumatic stress disorder characteristics of Holocaust survivors and their adult offspring. Am J Psychiatry (1998) 1.96

Low urinary cortisol excretion in patients with posttraumatic stress disorder. J Nerv Ment Dis (1990) 1.63

Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder. Arch Gen Psychiatry (1995) 1.53

Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder. Biol Psychiatry (1991) 1.52

Dissociation in aging Holocaust survivors. Am J Psychiatry (1996) 1.42

Urinary free-cortisol levels in posttraumatic stress disorder patients. J Nerv Ment Dis (1986) 1.35

Choline acetyltransferase activity is increased in combined cultures of spinal cord and muscle cells from mice. Science (1973) 1.19

Glucocorticoid receptor number and cortisol excretion in mood, anxiety, and psychotic disorders. Biol Psychiatry (1993) 1.18

Impact of cumulative lifetime trauma and recent stress on current posttraumatic stress disorder symptoms in holocaust survivors. Am J Psychiatry (1995) 1.18

Lymphocyte glucocorticoid receptor number in posttraumatic stress disorder. Am J Psychiatry (1991) 1.17

The role of marital interaction in chronic pain and depressive symptom severity. J Psychosom Res (1990) 1.17

Choline acetyltransferase activity of spinal cord cell cultures increased by co-culture with muscle and by muscle-conditioned medium. J Cell Biol (1977) 1.16

The Pain Behavior Check List (PBCL): factor structure and psychometric properties. J Behav Med (1991) 1.13

Personality disorders in treatment-seeking combat veterans with posttraumatic stress disorder. Am J Psychiatry (1993) 1.04

Urinary catecholamine excretion and severity of PTSD symptoms in Vietnam combat veterans. J Nerv Ment Dis (1992) 0.99

Long-lasting hormonal alterations to extreme stress in humans: normative or maladaptive? Psychosom Med (1993) 0.96

Sustained urinary norepinephrine and epinephrine elevation in post-traumatic stress disorder. Psychoneuroendocrinology (1987) 0.94

Exposure to atrocities and severity of chronic posttraumatic stress disorder in Vietnam combat veterans. Am J Psychiatry (1992) 0.89

Catechol-O-methyltransferase activity in cultured human skin fibroblasts from controls and patients with dystonia musculorum deformans. J Neurosci Res (1981) 0.88

Elevation of urinary norepinephrine/cortisol ratio in posttraumatic stress disorder. J Nerv Ment Dis (1988) 0.86

Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J Nerv Ment Dis (1991) 0.86

Alexithymia in Holocaust survivors with and without PTSD. J Trauma Stress (1997) 0.86

Classification of depression by grade of membership: a confirmation study. Psychol Med (1989) 0.86

Serum testosterone differences between patients with schizophrenia and those with affective disorder. Biol Psychiatry (1988) 0.85

Cerebral laterality, symptoms, and diagnosis in psychotic patients. Biol Psychiatry (1991) 0.84

Assessment of alexithymia in posttraumatic stress disorder and somatic illness: introduction of a reliable measure. Psychosom Med (1986) 0.84

A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder. Am J Psychiatry (1988) 0.83

Altered platelet alpha 2-adrenergic binding sites in posttraumatic stress disorder. Am J Psychiatry (1987) 0.82

Psychological dimensions of depression in borderline personality disorder. Am J Psychiatry (1995) 0.81

Depressive features in Holocaust survivors with post-traumatic stress disorder. J Trauma Stress (1994) 0.81

Monoamine oxidase type A in fibroblasts from patients with bipolar depressive illness. Psychiatry Res (1980) 0.81

Multidimensional hormonal discrimination of paranoid schizophrenic from bipolar manic patients. Biol Psychiatry (1991) 0.80

An efficacy study of isocarboxazid and placebo in depression, and its relationship to depressive nosology. Arch Gen Psychiatry (1988) 0.80

Characterization of depression in war-related posttraumatic stress disorder. Am J Psychiatry (1991) 0.79

Serum thyroxine change and clinical recovery in psychiatric inpatients. Biol Psychiatry (1989) 0.79

Mania secondary to amantadine treatment of neuroleptic-induced hyperprolactinemia. J Clin Psychiatry (1989) 0.78

Monoamine oxidase and catechol-O-methyltransferase activities in cultured fibroblasts and blood cells from children with autism and the Gilles de la Tourette syndrome. Psychiatry Res (1980) 0.78

Cimetidine psychotoxicity without significant medical illness: case report. J Clin Psychiatry (1983) 0.77

Neurotransmitter metabolism in cell culture. Biochem Pharmacol (1976) 0.77

Relationship of age to TSH response to TRH in depressed men. Acta Psychiatr Scand (1988) 0.77

Prolactin response to low-dose dexamethasone challenge in combat-exposed veterans with and without posttraumatic stress disorder and normal controls. Biol Psychiatry (1996) 0.76

Serum thyroxine levels in schizophrenic and affective disorder diagnostic subgroups. J Nerv Ment Dis (1989) 0.76

Lack of significant cortisol and growth hormone changes in Israeli civilians during the Gulf War. Am J Psychiatry (1995) 0.76

The dexamethasone suppression test in a group of research diagnostic criteria schizoaffective depressed men. Neuropsychobiology (1991) 0.75

Platelet MAO Vmax and Km in chronic schizophrenic subjects. Am J Psychiatry (1980) 0.75

Antidepressants in the treatment of PTSD. Am J Psychiatry (1990) 0.75

Predictors of response to monoamine oxidase inhibitors: do they exist? Eur Arch Psychiatry Clin Neurosci (1991) 0.75

Possible subtypes of affective disorder suggested by differences in cerebral laterality and testosterone. A preliminary report. Arch Gen Psychiatry (1989) 0.75

Irritability as a symptom of depression in the elderly. J Am Geriatr Soc (1988) 0.75

Neuroendocrine responses in alcoholics to the presentation and consumption of a perceived alcoholic beverage. Alcohol Clin Exp Res (1991) 0.75

Psychoneuroendocrine assessment of posttraumatic stress disorder: current progress and new directions. Prog Neuropsychopharmacol Biol Psychiatry (1993) 0.75

[The diagnosis of ischemic heart disease in coal miners]. Vrach Delo (1990) 0.75

[The professional nursing practice of 3d-year students at a medical institute]. Vrach Delo (1989) 0.75

Psychosocial care in a medical genetics clinic. Gen Hosp Psychiatry (1981) 0.75

Human skin fibroblasts in neuropsychiatric disorders. Psychopharmacol Bull (1980) 0.75

Prolactin response to thyrotropin-releasing hormone in schizoaffective depressed compared to depressed and schizophrenic men and healthy controls. Schizophr Res (1991) 0.75

[Various problems of teaching the methods of direct examination of the patient]. Klin Med (Mosk) (1991) 0.75

Chronic amitriptyline toxicity. Am J Psychiatry (1979) 0.75

Low platelet monoamine oxidase activity in borderline personality disorder. Psychiatry Res (1989) 0.75

Chronic depression: response to amitriptyline after discontinuation. Biol Psychiatry (1982) 0.75

Lifetime course of chronic depression in older men. J Geriatr Psychiatry Neurol (1989) 0.75

Platelet alpha 2-adrenergic receptor binding sites in major depressive disorder and borderline personality disorder. Psychiatry Res (1990) 0.75

Thyrotropin response to thyrotropin-releasing hormone in RDC schizodepressed men. J Affect Disord (1988) 0.75

Altered platelet alpha 2-adrenergic receptor binding sites in borderline personality disorder. Am J Psychiatry (1990) 0.75